Lifestyle interventions for patients with and at risk for type 2 diabetes (nov 2013)
New approaches in research and development of anti-diabetic drugs: An industry perspective (2012)
Adipose tissue and cancer (2013)
Diabetes treatment in 2025: Can scientific advances keep pace with prevalence? (2012)
Type 1 diabetes and cardiovascular disease (oct 2013)
Vitamin D and glycemic control in diabetes mellitus type 2 (sep 2013)
Acute Diabetes Management (2013)
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review (2013)
Hypertension management algorithm for type 2 diabetic patients applied in primary care (sep 2013)
The cardiovascular safety of incretin-based therapies: A review of the evidence (sep 2013)
Influence of gut microbiota on subclinical inflammation and insulin resistance (may 2013)
Bulking up on beta cells (ago 2013)
Metformin vs insulin in the management of gestational diabetes: A meta-analysis (may 2013)
Randomized trial of metformin vs insulin in the management of gestational diabetes (jul 2013)
In vivo actions of peroxisome proliferator – activated receptors (ago 2013)
Cardiovascular risk factor investigation: A pediatric issue (2013)
Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes (ago 2013)
Improving prediction algorithms for cardiometabolic risk in children and adolescents (2013)
Do we still need pioglitazone for the treatment of type 2 diabetes? (ago 2013)
Immune cells fuel the fire (2011)
The mechanism of white and brown adipocyte differentiation (2013)
Acylcarnitines: Reflecting or inflicting insulin resistance (ene 2013)
GPR40 Modulators: New Kid on the block (feb 2013)
Metformn: An old but still the best treatment for type 2 diabetes (feb 2013)
Nlrp3 inflammasome activation in type 2 diabetes: Is it clinically relevant? (ene 2013)
Pharmacological approach to cardiovascular risk in metabolic syndrome (2013)
Insulin Therapy for the management of hyperglycemia in hospitalized patients (2012)
Screening for coronary artery disease in type 2 diabetes (2012)
Sleep-wake cycle irregularities in type 2 diabetics (2012)
Statins: Is it really time to reassess benefits and risks (2012)
Update on insulin therapy for type 2 diabetes (2012)
Major lipids, apolipoproteins and risk of vascular disease (2009)
Summary of the DCCT/EDIC study (2005)
A clinical trial to maintain glycemic control in youth with type 2 diabetes (2012)
Exercise therapy in type 2 diabetes (2012)
Metabolic syndrome in central Brazil: Prevalence and correlates in the adult population (2012)
The skin function: A factor of anti-metabolic syndrome (2012)
Vascular memory: Can we broaden the concept of the metabolic memory? (2012)
Management of hyperglycemia in type 2 diabetes: A patient-centered approach (2012)
New insights into mechanisms of hypertension (2012)
Towards understanding the inherited susceptibility for nephropathy in diabetes (2012)
Measurement of insulin resistance in chronic kidney disease (2011)
Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus (2011)
ADA – Diagnosis and Classification of Diabetes Mellitus (2011)
Pharmacokinetics of Metformin during pregnancy (2010)
Hypertension – The clinical management of primary hypertension in adults (2011)
Effects of metformin on early pregnancy loss in the polycystic ovary syndrome (2002)
Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction (2011)
Adipokines in inflammation and metabolic disease (2011)
Treating diabetes with bariatric surgery (2009)
ESC/EAS Guidelines for the management of dyslipidaemias: Addenda (2011)
Mody – History, genetics, pathophysiology and clinical decision marking (2011)
NORMA oficial Mexicana NOM-008-SSA3-2010, para el tratamiento integral del sobrepeso y la obesidad
Metabolic syndrome: Nature, therapeutic solutions and options (2011)
IDF – President´s statement on who recommendation on HbA1c for diabetes diagnosis
Consenso ALAD – Prevención, diagnóstico y tratamiento temprano de la Nefropatía diabética
Nutrition support in critical illness – Bridging the evidence gap (2011)
Noncomunicable diseases country (2011)
Postprandial Glucose: Maker or Risk Factor? (2011)
World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) – Part 1 -
World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) – Part 2 -
World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) – Part 3 -
World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) – Part 4 -
The role of advanced glycation end products in progression and complications of diabetes (2008)
The role of “metabolic memory” in the natural history of diabetes mellitus (2009)
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes (2008)
Fixed-dose single tablet antidiabetic combinations (2008)
Resistence: central and peripheral mechanisms (2007)
Prevalencia del Síndrome Metabólico entre adultos mexicanos (enero-marzo 2008)
Obesity, insuline resistance (March 2008)
Neurobiology of the metabolic syndrome: An allostatic perspective (2008)
Patient-oriented and epidemiological research (2009)
Rosavastatin and Cardiovascular Events in Patients undergoing Hemodialysis (2009)
Intrauterine growth restriction and adult disease: the role of adipocytokines (2009)
Glucose Control in the ICU-How tight is too tight? (2009)
Intensive Versus conventional Glucose control in critically ill patients (2009)
